CYTOCRISTIN 1MG INJECTION

Cytocristin 1mg Injection contains vincristine, a well-established vinca alkaloid chemotherapy agent widely used in oncology for the treatment of acute leukemias, lymphomas, and a variety of solid tumors. Vincristine interferes with the formation of microtubules in cancer cells, effectively halting cell division and slowing tumor growth. Due to its proven efficacy, Cytocristin Injection is an essential component of many combination chemotherapy regimens used by oncologists worldwide.

This anticancer injection is administered intravenously and must be given strictly under the supervision of a qualified oncologist in a hospital or specialized oncology center. Cytocristin 1 mg Injection is commonly included in treatment protocols for pediatric and adult cancers, where precise dosing and controlled administration are critical for patient safety. As a prescription-only medicine, it ensures regulated use in clinical settings to maintain optimal therapeutic outcomes.

Cytocristin 1 mg Injection meets international quality and safety standards required for chemotherapy medicines. It is supplied in secure packaging suitable for hospital, institutional, and export requirements. Healthcare providers and distributors seeking a reliable vincristine injection can source Cytocristin 1 mg Injection as a trusted solution for advanced cancer treatment protocols.

Product Features

• Potent anticancer chemotherapy injection
• Contains Vincristine 1 mg
• Vinca alkaloid antineoplastic agent
• Used in leukemia, lymphoma, and solid tumours
• Intravenous administration only
• Sterile injectable formulation
• Manufactured under GMP-compliant standards
• Prescription-required oncology medicine

How It Helps

• Inhibits cancer cell division by blocking microtubule formation
• Slows the growth and spread of leukemia, lymphoma, and solid tumors.
• Destroys rapidly multiplying cancer cells in chemotherapy regimens
• Supports effective cancer treatment under an oncologist’s supervision